Myeloma Minute: Largest Screening Study of Myeloma


| INNOVATION | Latest Research


Early results from massive, IMF-supported Iceland study

Launched three years ago, the iStopMM project is assessing the impact and outcomes from early screening for MGUS, smoldering myeloma, and active myeloma for the whole of Iceland. The participation rate (approximately 80,000 adults over age 40 volunteered to take part) makes it the largest screening project for any type of cancer ever conducted. Today, IMF Chairman Brian G.M. Durie, MD shares a sneak peek from Reykjavik of the study’s most exciting early findings.


| INNOVATION | Clinical Trials


| ACTION | Cancer Drug Parity


Phase III TOURMALINE-MM4 Study Meets Primary Endpoint
IMF Support Group Leader Advocates for Drug Access

The Phase III TOURMALINE-MM4 study has met its primary endpoint of progression-free survival (PFS). "The trial evaluated the effect of single-agent oral NINLARO™ (ixazomib) as a first line maintenance therapy versus placebo in adult patients diagnosed with multiple myeloma not treated with stem cell transplantation."

Diagnosed with multiple myeloma in 2013, Tiffany Williams is a patient advocate and IMF Support Group Leader. Read about how Tiffany advocates in South Carolina for the Cancer Drug Parity Act of 2019. As she says about oral chemotherapy medications, “Some patients don’t have access to these life-saving medications. That has to change.”



| INSPIRATION | Ways to Give


Shop Your Favorite Merchants and Give to the IMF at the Same Time

Did you know that you can shop leading merchants, pay the same price as everyone else, and support the IMF at the same time? Bookmark and find portals to such sites as Nordstrom, The Sharper Image, Best Buy, Champion,, New Balance, Sam’s Club, Walmart, and more!


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



Search the Myeloma Matrix 2.0

Join the conversation about myeloma on the Smart Patients Message Board

Clinical Trial Fact Sheets

OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)

November 16, 2019
IMF Regional Community Workshop
Columbia, MD

January 10, 2020
Magical Miles for Myeloma
Walt Disney World - Orlando

March 13-14, 2020
IMF Patient & Family Seminar
Boca Raton, FL

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Celgene Corporation, Genentech, and Takeda Oncology

We also thank individuals like you for your continued support!

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.